Search
for

    GlossaryHirsutism

    excessive male-pattern hair growth in women due to androgens

    Hirsutism is a condition characterized by excessive, male-pattern hair growth in women, typically on areas where men usually grow hair, such as the face, chest, and back. This condition is often caused by an excess of androgens (male hormones) and can be associated with underlying medical issues like polycystic ovary syndrome (PCOS) or adrenal gland disorders.

    Related Terms

    Products matching "hirsutism"

    Tracking 2 products like 100 RU58841 Powder and 265 RU-58841 Solution 50mg/ml – 50ml from by companies like MinoxidilMax and Chemyo. View all 2 products »

    Learn

    5 / 5 results

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Spironolactone

      powerful topical and oral anti-androgen used mostly by women

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

    Research

    5 / 1000+ results

    Community Join

    5 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.